Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1993
12/23/1993WO1993025228A1 Cytotoxins specific for gm-csf receptor-bearing cells
12/23/1993WO1993025227A1 Use of growth factor igf-ii
12/23/1993WO1993025226A1 Use of growth factor igf-i and/or igf-ii
12/23/1993WO1993025224A1 Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach cancer and breast cancer
12/23/1993WO1993025223A1 Rxr homodimer formation
12/23/1993WO1993025222A1 Stabilized somatotropin for parenteral administration
12/23/1993WO1993025221A1 Erythropoietin drug delivery system
12/23/1993WO1993025219A1 Prevention and treatment of peripheral neuropathy
12/23/1993WO1993025218A1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
12/23/1993WO1993025217A1 Des-tyr dynorphin analogues
12/23/1993WO1993025215A1 Device for producing a supernatant of activated thrombocytes, method for implementing the device and supernatant obtained
12/23/1993WO1993025212A1 Polyoxymethylene-oxyethylene copolymers in conjunction with biomolecules
12/23/1993WO1993025210A1 Diphtheria toxin vaccines
12/23/1993WO1993025209A1 Compositions for the treatment and prophylaxis of inflammations and dermatoses induced by viruses and process for the preparation thereof
12/23/1993WO1993025071A1 Production of human hemoglobin in transgenic pigs
12/23/1993WO1993022434A3 Targeted cleavage of rna using eukaryotic ribonuclease p and external guide sequence
12/23/1993WO1993017031A3 Nucleic acids encoding dystrophin-associated proteins
12/23/1993DE4219626A1 Incorporating therapeutic gene via vector into body cells - in=vivo or in vitro, for subsequent expression and secretion of active protein, partic. for treating degenerative diseases of spine and nerves
12/23/1993CA2138277A1 Polyoxymethylene-oxyethylene copolymers in conjunction with biomolecules
12/23/1993CA2138151A1 New polypeptides with a nmda receptor activity, nucleic acid coding for these polypeptides and their use
12/23/1993CA2138146A1 Proteinoid carriers and methods for preparation and use thereof
12/23/1993CA2137916A1 Des-tyr dynorphin analogues
12/23/1993CA2137911A1 Production of human hemoglobin in transgenic pigs
12/23/1993CA2137829A1 Active component of parathyroid hypertensive factor
12/23/1993CA2137814A1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors
12/23/1993CA2137813A1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
12/23/1993CA2137799A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression
12/23/1993CA2137547A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof
12/23/1993CA2137367A1 Peptides having platelet-derived growth factor (pdgf) activity
12/23/1993CA2137361A1 Vector particles resistant to inactivation by human serum
12/23/1993CA2136724A1 Recombinant pseudomonas exotoxin with increased activity
12/23/1993CA2136641A1 The use of hyperimmune milk to increase longevity
12/23/1993CA2135397A1 T-cell membrane inducing factors
12/23/1993CA2134752A1 Monoclonal antibodies to glycoprotein p
12/23/1993CA2114420A1 Use of growth factor igf-ii
12/23/1993CA2114419A1 Use of growth factor igf-i and/or igf-ii
12/23/1993CA2096004A1 Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered bile acids
12/22/1993EP0575097A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS
12/22/1993EP0575054A2 Protein C derivatives
12/22/1993EP0574955A1 Production and use of IL-6
12/22/1993EP0574758A1 Hydroxamic acid derivatives as collagenase inhibitors
12/22/1993EP0574638A1 Soluble dextran-glutathione complexes, method of preparing same and their use
12/22/1993EP0574579A1 Dna encoding a human 5-ht 1f? receptor and uses thereof
12/22/1993EP0574530A1 Endothelin antagonists
12/22/1993EP0574512A1 Redirection of cellular immunity by receptor chimeras
12/22/1993EP0574506A1 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
12/22/1993EP0574461A1 High affinity humanized monoclonal antibodies
12/22/1993EP0574414A1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES
12/22/1993EP0574395A1 Cytokine immunoconjugates
12/22/1993EP0574391A1 Antibodies against the urokinase receptor and their use
12/22/1993EP0482124B1 Somatotropin analogs
12/22/1993EP0440633B1 Pharmaceutical for treating tumors in humans and method for making it
12/22/1993EP0383777B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
12/22/1993CN1079825A Immunochemical detection of in vivo advanced glycosylation endproducts
12/22/1993CN1079780A 生产重组人体乳铁蛋白 Production of recombinant human lactoferrin
12/21/1993US5272268 Dipeptide derivatives
12/21/1993US5272266 Vinylsulphonylpristinamycin and its preparation
12/21/1993US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS)
12/21/1993US5272262 Method for the production of catalytic RNA in bacteria
12/21/1993US5272258 Monoclonal antibodies to C-reactive protein
12/21/1993US5272256 Nuclear autoantigen
12/21/1993US5272255 Polypeptide factors from colostrum
12/21/1993US5272253 Cluster conjugates of drugs with antibodies
12/21/1993US5272252 Synthetic lung surfactant having antioxidant properties
12/21/1993US5272176 Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use
12/21/1993US5272166 Method for selective reduction of Lp(a)
12/21/1993US5272165 2-alkylidene-aminoguanidines and methods of use therefor
12/21/1993US5272151 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances
12/21/1993US5272135 Method for the stabilization of methionine-containing polypeptides
12/21/1993US5272082 Cytotoxic T-ALL cell lines and uses therefor
12/21/1993US5272080 Production of butyrylcholinesterase
12/21/1993US5272079 Purification and administration of DNA repair enzymes
12/21/1993US5272076 Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA
12/21/1993US5272065 Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
12/21/1993US5272064 DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
12/21/1993US5272063 Process of making human nerve growth factor
12/21/1993US5272059 Monoclonal antibodies specific for hirudin
12/21/1993US5271942 Agent for reducing the growth of or removing the hair on the human body
12/21/1993US5271941 Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
12/21/1993US5271939 Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation
12/21/1993US5271931 Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6
12/21/1993CA1325497C Compounds as superior renin inhibitors
12/20/1993CA2098777A1 Production of human cathepsin and its use
12/20/1993CA2098639A1 Bone stimulating, non-vasoactive parathyroid hormone variants
12/20/1993CA2098165A1 Inhibitors of hiv protease useful for the treatment of aids
12/19/1993CA2098655A1 Bradykinin antagonist peptidic derivatives, process for preparing them and phamaceutical compositions containing same
12/19/1993CA2098535A1 Linear peptides
12/15/1993EP0574174A2 Angiotensin II antagonists
12/15/1993EP0574029A1 Recombinant DNA molecules
12/15/1993EP0573904A1 Therapeutic agent for neutropenia
12/15/1993EP0573668A1 Bone reinforcing factor, and food and drink containing said factor
12/15/1993EP0573611A1 Improved epitode displaying phage
12/15/1993EP0573608A1 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
12/15/1993EP0573605A1 Preparation of factor ix
12/15/1993EP0573603A1 Inhibitors of human neutrophil elastase and human cathepsin g
12/15/1993EP0573545A1 Monoclonal antibodies against receptor-induced binding sites
12/15/1993EP0573544A1 Intestinal trefoil proteins
12/15/1993EP0573540A1 Process for the c-terminal modification of peptides having a c-terminal penultimate proline residue
12/15/1993EP0573510A1 Anti-growth factor antibodies in the treatment of vascular stenosis
12/15/1993EP0573499A1 Process for the phosphorylation of insulin and product produced thereby.
1 ... 2912 2913 2914 2915 2916 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 ... 3163